Biotech news for Friday, May 29, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Q32 Bio Inc. ( QTTB ) announced on Wednesday that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors for the private placement of common stock and pre-funded warrants for an aggregate of
Shares of BridgeBio Pharma ( BBIO ) traded higher on Wednesday after the FDA granted priority review for its marketing application for BBP-418, an oral therapy targeting a rare muscle disorder called limb-girdle muscular dystrophy. The regulator has assigned N…
Md Saiful Islam Khan/iStock via Getty Images TG Therapeutics ( TGTX ) announced on Wednesday that its Phase 3 ENHANCE trial evaluating a consolidated single-infusion, considered for initial dosing of its top-selling drug, Briumvi, met the primary endpoint. The…
HCW Biologics ( HCWB ) has exercised its option to regain full ex vivo rights to HCW9206 and HCW9201, two commercial-ready compounds as reagents, from its licensee, Wugen Inc. Wugen held exclusive worldwide rights to these two compounds for ex vivo, cell-based…
gesrey/iStock via Getty Images The Italian Competition Authority on Wednesday announced an investigation into Biogen ( BIIB ) over alleged abuse of market dominance to sell a multiple sclerosis medication in Italy, rivaling a reference product from Sandoz ( SD…
Apogee Therapeutics ( APGE ) shares fell over -27% premarket after it announced a strategic financing collaboration with funds managed by Blackstone Life Sciences ( BX ). The collaboration agreement provides for up to $1.3B in flexible, non-dilutive total capi…